Novo Nordisk

+$0.71 (+0.67%) As of 4:08 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.

CEO

Lars Fruergaard Jørgensen

Employees

45,323

Headquarters

Bagsværd, Capital Region

Founded

1925

NVO Key Statistics

Market Cap

Price-Earnings Ratio

34.50

Dividend Yield

0.99

Average Volume

777.98K

High Today

$107.04

Low Today

$105.43

Open Price

$105.43

Volume

281.02K

52 Week High

$107.24

52 Week Low

$63.22

NVO News

Simply Wall StOct 23

Here's Why I Think Novo Nordisk (CPH:NOVO B) Is An Interesting Stock

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it completely lacks a trac

Barron'sOct 21

Raymond James’ $1.1B Deal for TriState Puts Spotlight on Securities-Based Lending

Motley Fool It's not that difficult to spread your investments out across many companies and hope for the best over a long time horizon. Another took a differe

Analyst Ratings

46%

of 28 ratings

Buy

46.4%

Hold

32.1%

Sell

21.4%

NVO Earnings

$0.00

$0.29

$0.59

$0.88

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Nov 3, Pre-Market

Why Robinhood?

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. View more

Here's Why I Think Novo Nordisk (CPH:NOVO B) Is An Interesting Stock

Raymond James’ $1.1B Deal for TriState Puts Spotlight on Securities-Based Lending

46%

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.